> ## Content Index > Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt > Use this file to discover other available public pages before exploring further. # CMS draft guidance on manufacturer effectuation of negotiated drug prices, first cycle to include Part B - URL: https://members.americanhealthintel.com/2026-07-20-regulator/ - Published: 2026-07-20T13:35:51.000Z - Updated: 2026-07-20T13:35:51.000Z - Description: Plus: DOJ says it will stop relying on 2011 Olmstead integration-mandate enforcement guidance. The day's rules, money, and enforcement, sourced and tiered below. - Author: American Health Intel Plus: DOJ says it will stop relying on 2011 Olmstead integration-mandate enforcement guidance. The day's rules, money, and enforcement, sourced and tiered below. | American Health Intel Rules · Money · Medicine · Decoded daily The Regulator Monday, July 20, 2026 CMS draft guidance on manufacturer effectuation of negotiated drug prices, first cycle to include Part B Plus: DOJ says it will stop relying on 2011 Olmstead integration-mandate enforcement guidance. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Rule Confidence: High CMS just published guidance on the hardest problem in Medicare drug price negotiation, the program that sets discounted prices for costly drugs: how manufacturers pay out the discount when a doctor administers the drug in-office. The guidance covers 15 drugs including Botox, Cimzia, Orencia and Entyvio, the first cycle to include physician-administered drugs. 1.8M beneficiaries, $27B in spending. Prices effective Jan 1, 2028\. Comments due Sept 18, 2026. Why it matters This is the first test of Medicare's drug price negotiation program on drugs your doctor administers in office rather than ones you pick up at a pharmacy, and the mechanics are still being worked out. Sources: [Federal Register](https://www.federalregister.gov/documents/2026/07/20/2026-14583/medicare-program-inflation-reduction-act-of-2022-ira-medicare-drug-price-negotiation-program-draft?ref=members.americanhealthintel.com) · [CMS](https://www.cms.gov/priorities/medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation-program/guidance-policy-documents?ref=members.americanhealthintel.com) Rule Confidence: High The Justice Department just said it will stop relying on the 15-year-old guidance that has directed states to move people with disabilities out of institutions and into community care whenever possible. The underlying Supreme Court ruling in Olmstead v. L.C. still stands, but disability rights advocates say DOJ just pulled the practical roadmap it has used to enforce it. Notice dated July 13, published July 20, 2026. Why it matters The Supreme Court ruling that people with disabilities have a right to community based care instead of institutionalization is unchanged, but the government just pulled the practical guidance it used to enforce it. Sources: [Federal Register](https://www.federalregister.gov/documents/2026/07/20/2026-14566/clarification-on-department-of-justice-guidance-titled-statement-of-the-department-of-justice-on?ref=members.americanhealthintel.com) · [Ada](https://www.ada.gov/resources/olmstead-mandate-statement/?ref=members.americanhealthintel.com) Also today State AGs allege ICE shared Medicaid data with Palantir, dispute over deletion [Read](https://americanhealthintel.com/editions/2026-07-20-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#ice-medicaid-data-palantir-california-v-hhs) Senate HELP Committee votes this week on insulin cap bill and CDC director nomination [Read](https://americanhealthintel.com/editions/2026-07-20-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#senate-help-insulin-act-cdc-nominee-votes) House Ways and Means advances Medicare Advantage transparency bill, splits on price certainty bill [Read](https://americanhealthintel.com/editions/2026-07-20-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#ways-means-ma-mlr-transparency-price-certainty) HHS and VA sign 5-year MOU on psychedelic therapy research for veterans [Read](https://americanhealthintel.com/editions/2026-07-20-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#hhs-va-psychedelic-therapy-veterans-mou) 177Records$16.0BEnforcement7Deadlines65Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-07-20-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) | | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |